Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases

References

• Ghazale A, Chan ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102:1646–53.
   PubMed Web of Science ®Google Scholar
• Choi EK, Kim MH, Lee TY, et al. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean expe-rience. Pancreas. 2007;35:156–61.
   PubMed Web of Science ®Google Scholar
• Morselli-Labate AM, Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: a systematic literature review and meta-analysis. J Gastroenterol Hepatol. 2009;24: 15–36.
   Google Scholar
• Song TJ, Kim MH, Moon SH, et al. The combined measurement of total serum IgG and IgG4 may increase diagnostic sensitivity for autoimmune pancreatitis without sacrificing sensitivity, compared with IgG4 alone. Am J Gastroenterol. 2010;105:1655–60.
   PubMed Web of Science ®Google Scholar
• Sadler R, Chapman RW, Simpson D, et al. The diagnostic signifi-cance of serum IgG4 levels in patients with autoimmune pancreatitis: a UK study. Eur J Gastroenterol Hepatol. 2011;23:139–45.
   PubMed Web of Science ®Google Scholar
• Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic cri-teria of autoimmune pancreatitis: revised proposal. J Gastroen-terol. 2006;41:626–31.
   PubMed Web of Science ®Google Scholar
• Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010–6.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythe-matosus. Arthritis Rheum. 1997;40:1725.
   PubMed Web of Science ®Google Scholar
• Miyakis S, Lockshin MD, Atsumi T, et al. International con-sensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569–81.
   Web of Science ®Google Scholar
• Subcommittee for Scleroderma Criteria of the American Rheu-matism Association Diagnostic and Therapeutic Criteria Com-mittee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581–90.
   PubMed Web of Science ®Google Scholar
• Bohan A, Peter JB, Bowman RL, et al. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore). 1977;56:255–86.
   PubMed Web of Science ®Google Scholar
• Alarcon-Segovia D, Cardiel MH. Comparison between 3 diag-nostic criteria for mixed connective tissue disease: study of 593 patients. J Rheumatol. 1989;16: 328–34.
   Google Scholar
• Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.
   PubMed Web of Science ®Google Scholar
• International Study Group for Behçet's Disease. Evaluation of diagnostic ("classification") criteria in Behget's disease-towards internationally agreed criteria. Br J Rheumatol. 1992;31: 299–308.
   Google Scholar
• Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum. 1999;42:421–30.
   PubMed Web of Science ®Google Scholar
• Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33:1094–100.
   PubMed Web of Science ®Google Scholar
• van Gestel AM, Prevoo ML, van't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/ International League Against Rheumatism Criteria. Arthritis Rheum. 1996;39:34–40.
   Google Scholar
• Clements PJ, Lachenbruch PA, Seibold JR, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheum. 1995;22:1281–5.
   PubMed Web of Science ®Google Scholar
• Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 con-centrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Harada S, Ohara M, et al. Clinical and patho-logical differences between Mikulicz's disease and Sjögren's syndrome. Rheumatology (Oxf). 2005;44:227–34.
   PubMed Web of Science ®Google Scholar
• van der Giessen M, Rossouw E, van Teen TA. Quantification of IgG subclasses in sera of normal adults and healthy children between 4 and 12 years of age. Clin Exp Immunol. 1975;21: 501–9.
   PubMed Web of Science ®Google Scholar
• Schur PH, Rosen F, Norman ME. Immunoglobulin subclasses in normal children. Pediatr Res. 1979;13:181–3.
   Google Scholar
• Schauer U, Stemberg F, Rieger CH, et al. IgG subclass concen-tration in certified reference material 470 and reference values for children and adults determined with the binding site reagents. Clin Chem. 2003;49:1924–9.
   PubMed Web of Science ®Google Scholar
• Leddy JP, Deitchman J, Bakemeier RF. IgG subclasses mea-surement of radioimmunoassay in normal and hypogammaglob-ulinaemic sera. Arthritis Rheum. 1970;13:331–2.
   Google Scholar
• More11 A, Skavaril F. A modified radioimmunoassay for quanti-tative determination of IgG subclasses in man. Prot Biol Fluids. 1971;19:533–40.
   Google Scholar
• Shakib F, Stanworth DR, Drew R, et al. A quantitative study of the distribution of IgG sub-classes in a group of normal human sera. J Immunol Methods. 1975;8:17–28.
   PubMed Web of Science ®Google Scholar
• Oxelius V. Crossed immunoelectrophoresis and electroimmuno-assay of human IgG subclass. Acta Path Microbiol Scand Sect C. 1978;86:109–18.
   Google Scholar
• French MAH, Harrison G. Serum IgG subclass concentration in healthy adults: a study using monoclonal antisera. Clin Exp Immnol. 1984;56:473–5.
   PubMed Web of Science ®Google Scholar
• Milford-Ward A, White PAE, French MAH, et al. A calibration material for IgG subclass assay. J Clin Lab Immunol. 1984; 14:209–10.
   PubMedGoogle Scholar
• Klein F, Skvaril F, Vermeeren R, et al. The quantification of human IgG subclasses in reference preparations. Clin Chim Acta. 1985;150:119–27.
   PubMed Web of Science ®Google Scholar
• Maddessery JV, Kwon OH, Lee SY, et al. IgG2 subclass defi-ciency: IgG subclass assay and IgG2 concentrations among 8015 blood donors. Clin Chem. 1988;34:1407–13.
   PubMed Web of Science ®Google Scholar
• Carr-Smith HD, Overton J, Bradwell AR. IgG subclass value assignment to the protein reference preparation CRM 470. Clin Chem. 1997;43\(Suppl 6):5238.
   Google Scholar
• Yamamoto M, Ohara M, Suzuki C, et al. Elevated IgG4 con-centrations in serum of patients with Mikulicz's disease. Scand J Rheumatol. 2004;33:432–3.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Takahashi H, Suzuki C, et al. Analysis of serum IgG subclasses in Churg-Strauss syndrome-the meaning of elevated serum levels of IgG4. Intern Med. 2010;49:1365–70.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Takahashi H, Suzuki C, et al. The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome (SIPS)-expansion of SIPS to the territory of Castle-man's disease. Rheumatology (Oxf). 2009;48:860–2.
   PubMed Web of Science ®Google Scholar
• Shinoda K, Matsui S, Taki H, et al. Deforming arthropathy in a patient with IgG4-related systemic disease: comment on the article by Stone et al. Arthritis Care Res (Hoboken). 2011;63:172.
   PubMed Web of Science ®Google Scholar
• Engelmann R, Brandt J, Eggert M, et al. IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrul-finated antigens in RA. Rheumatology (Oxf). 2008;47:1489–92.
   PubMed Web of Science ®Google Scholar
• Bos WH, Bartelds GM, Vis M, et al. Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheuma-toid arthritis. Ann Rheum Dis. 2009;68:558–63.
   PubMed Web of Science ®Google Scholar
• Wang W, Li J. Identification of natural bispecific antibodies against cyclic citrullinated peptide and immunoglobulin G in rheumatoid arthritis. PLoS One. 2011;6:e16527.
   PubMed Web of Science ®Google Scholar
• Kuwana M, Okano Y, Pandey JP, et al. Enzyme-linked immu-nosorbent assay for detection of anti-RNA polymerase III anti-body: analytical accuracy and clinical associations in systemic sclerosis. Arthritis Rheum. 2005;52:2425–32.
   PubMed Web of Science ®Google Scholar
• Okazaki K, Uchida K, Koyabu M, Miyoshi H, Takaoka M. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol. 2011;46: 277–88.
   Google Scholar
• Hummelshoj L, Ryder LP, Poulsen LK. The role of the inter-leukin-10 subfamily members in immunoglobufin production by human B cells. Scand J Immunol. 2006;64: 40–7.
   Google Scholar
• Zen Y, Nakanuma Y. Pathogenesis of IgG4-related disease. Curr Opin Rheumatol. 2011;23:114–8.
   PubMed Web of Science ®Google Scholar
• Slobodin G, Ahmad MS, Rosner I, et al. Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity. Cell Immunol. 2010;261:77–80.
   PubMed Web of Science ®Google Scholar
• Sato S, Hasegawa M, Takehara K. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J Dermatol Sci. 2001;27: 140–6.
   Google Scholar
• Kirmaz C, Terzioglu E, Topalak 0, et al. Serum transforming growth factor-/31 (TGF-/31) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C. Eur Cytokine Netw. 2004;15: 112–6.
   Google Scholar
• Verma V, Chakravarti A, Kar P. Cytokine levels of TGF-beta, IL-10, and sTNFocRII in type C chronic liver disease. Dig Dis Sci. 2008;53: 2233–7.
   Google Scholar
• Ishida C, Ikebuchi Y, Okamoto K, Murawaki Y. Functional gene polymorphisms of interleukin-10 are associated with liver disease progression in Japanese patients with hepatitis C virus infection. Intern Med. 2011;50:659–66.
   PubMed Web of Science ®Google Scholar